IRIS
RUCCI, NADIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.569
EU - Europa 4.776
AS - Asia 4.703
SA - Sud America 526
AF - Africa 61
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 4
Totale 20.650
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.471
SG - Singapore 1.902
CN - Cina 1.143
RU - Federazione Russa 1.034
IE - Irlanda 963
IT - Italia 570
TR - Turchia 548
DE - Germania 544
BR - Brasile 462
HK - Hong Kong 443
VN - Vietnam 405
SE - Svezia 358
GB - Regno Unito 338
UA - Ucraina 310
FR - Francia 248
FI - Finlandia 195
IN - India 78
NL - Olanda 55
CA - Canada 48
JP - Giappone 42
PL - Polonia 33
MX - Messico 29
BE - Belgio 25
BD - Bangladesh 24
AT - Austria 21
ZA - Sudafrica 21
AR - Argentina 20
ES - Italia 20
LT - Lituania 20
CZ - Repubblica Ceca 17
IQ - Iraq 15
MA - Marocco 14
KR - Corea 12
EC - Ecuador 11
ID - Indonesia 11
PK - Pakistan 11
VE - Venezuela 11
AE - Emirati Arabi Uniti 9
AU - Australia 9
UZ - Uzbekistan 9
EG - Egitto 8
KE - Kenya 6
MY - Malesia 6
PY - Paraguay 6
SA - Arabia Saudita 6
AZ - Azerbaigian 5
CL - Cile 5
CO - Colombia 5
IL - Israele 5
JO - Giordania 5
DO - Repubblica Dominicana 4
PA - Panama 4
CH - Svizzera 3
DZ - Algeria 3
KZ - Kazakistan 3
PT - Portogallo 3
RO - Romania 3
TH - Thailandia 3
TN - Tunisia 3
BG - Bulgaria 2
BO - Bolivia 2
EU - Europa 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
KG - Kirghizistan 2
LB - Libano 2
LV - Lettonia 2
NP - Nepal 2
RS - Serbia 2
SN - Senegal 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DK - Danimarca 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
IM - Isola di Man 1
IR - Iran 1
IS - Islanda 1
KW - Kuwait 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MK - Macedonia 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
Totale 20.642
Salva come PNG Salva come JPEG
Città #
Dallas 3.247
Jacksonville 1.202
Singapore 1.134
Chandler 1.039
Dublin 961
San Jose 709
Hong Kong 436
Boardman 435
Ashburn 421
Santa Clara 399
Izmir 261
Nanjing 240
San Mateo 227
The Dalles 222
New York 191
L’Aquila 170
Wilmington 169
Lawrence 165
Princeton 165
Moscow 158
Beijing 128
Lauterbourg 123
Ho Chi Minh City 118
Ann Arbor 106
Hanoi 89
Milan 86
Nanchang 85
L'aquila 67
Los Angeles 64
Munich 61
Hefei 55
Shenyang 53
Seattle 49
Dong Ket 48
Council Bluffs 47
Woodbridge 47
Tianjin 44
Guangzhou 43
Rome 43
Bremen 42
Tokyo 41
Hebei 40
Amsterdam 37
São Paulo 37
Verona 35
Kitzingen 33
Kunming 32
Des Moines 31
Shanghai 31
Falkenstein 29
Mountain View 29
Jiaxing 28
Orem 28
Columbus 26
Warsaw 26
Norwalk 25
Brussels 24
Chennai 24
Turku 24
Frankfurt am Main 23
Helsinki 23
Jinan 23
Brooklyn 21
Phoenix 20
Da Nang 19
Dearborn 19
Falls Church 19
Montreal 19
Changsha 16
San Francisco 16
Chicago 15
Lanzhou 15
Brno 14
Johannesburg 14
London 14
Ningbo 14
Toronto 14
Zhengzhou 14
Denver 13
Houston 13
Lappeenranta 13
Mumbai 13
Pescara 13
Rio de Janeiro 13
Manchester 11
Nuremberg 11
Poplar 11
Taizhou 11
Tappahannock 11
Ankara 10
Atlanta 10
Belo Horizonte 10
Brasília 10
Philadelphia 10
Stockholm 10
Boston 9
Biên Hòa 8
Fremont 8
Hangzhou 8
Hải Dương 8
Totale 14.495
Salva come PNG Salva come JPEG
Nome #
(0) Save to: more options The matrix proline/arginine-rich end leucine-rich repeat protein (PRELP) inhibits osteoclastogenesis inactivating NF-kappaB signal 3.085
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 175
Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation 162
TrkA alternative splicing: A regulated tumor-promoting switch in human neuroblastoma 161
Interleukin-1β, lipocalin 2 and nitric oxide synthase 2 are mechano-responsive mediators of mouse and human endothelial cell-osteoblast crosstalk 155
RNA interference therapy for autosomal dominant osteopetrosis type 2. Towards the preclinical development 149
Anabolic and antiresorptive modulation of bone homeostasis by the epigenetic modulator sulforaphane, a naturally occurring isothiocyanate 144
A COMPLEX ROLE FOR LIPOCALIN 2 IN BONE METABOLISM: GLOBAL ABLATION IN MICE INDUCES OSTEOPENIA CAUSED BY AN ALTERED ENERGY METABOLISM 139
Characterization of the osteoblast-like cell phenotype under microgravity conditions in the NASA-approved Rotating Wall Vessel bioreactor (RWV) 138
Lipocalin 2 increases after high-intensity exercise in humans and influences muscle gene expression and differentiation in mice 138
Anti-osteoblastogenic, pro-inflammatory and pro-angiogenic effect of extracellular vesicles isolated from the human osteosarcoma cell line MNNG/HOS 136
c-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling 135
A gene expression signature from bone metastases as predictor of clinical outcome in breast cancer patients 135
Inhibition of protein kinase c-src reduces the incidence of breast cancer metastases and increases survival in mice: Implications for therapy 134
Non-conventional role of haemoglobin beta in breast malignancy 134
Bone cells and the mechanisms of bone remodelling 132
Ontogenesis and cell specific localization of Fas ligand expression in the rat testis 131
The unexpected role of Hemoglobin beta (HBB) in breast cancer. 131
Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targets. 131
c-Src inhibition decreases breast cancer-induced lethality and incidence of metastases in nude mice. 130
Effects of osteoblast-derived extracellular vesicles on aggressiveness, redox status and mitochondrial bioenergetics of MNNG/HOS osteosarcoma cells 129
The "love-hate" relationship between osteoclasts and bone matrix 129
TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis. 129
A novel protein kinase C alpha-dependent signal to ERK1/2 activated by alphaVbeta3 integrin in osteoclasts and in chinese hamster ovary (CHO) cells 128
The α2β1 binding domain of chondroadherin inhibits breast cancer-induced bone metastases and impairs primary tumour growth: A preclinical study 126
The N-terminal domain of the bone protein PRoline/arginine-rich End Leucine-rich repeat Protein (PRELP) impairs osteoclast formation by a new mechanism inhibiting NF-kappaB signaling 126
Transcriptomic and bioinformatic analysis of Clcn7-dependent Autosomal Dominant Osteopetrosis type 2. Preclinical and clinical implications 126
RNA methylation and cellular response to oxidative stress-promoting anticancer agents 125
Lipocalin 2 Influences Bone and Muscle Phenotype in the MDX Mouse Model of Duchenne Muscular Dystrophy 124
The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis 122
Apoptosi e spermatogenesi: implicazioni fisiopatologiche 122
Fas and Fas ligand expression in fetal and adult human testis with normal or deranged spermatogenesis 122
Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice 122
Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro 121
Extra-skeletal manifestations in mice affected by Clcn7-dependent autosomal dominant osteopetrosis type 2 clinical and therapeutic implications 121
Kinase-dependent and independent role of EphA2 in the regulation of prostate cancer invasion and metastasis 120
Effective small interfering RNA therapy to treat CLCN7-dependent autosomal dominant osteopetrosis type 2 120
An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6 120
the effect of microgravity on osteoblast metabolism 119
Increased expression of a set of genes enriched in oxygen binding function discloses a predisposition of breast cancer bone metastases to generate metastasis spread in multiple organs 119
Global Transcriptome Analysis in Mouse Calvarial Osteoblasts Highlights Sets of Genes Regulated by Modeled Microgravity and Identifies A "Mechanoresponsive Osteoblast Gene Signature" 119
Extracellular Vesicles From Osteotropic Breast Cancer Cells Affect Bone Resident Cells 119
Receptor Activator of NF-kappa B Ligand Enhances Breast Cancer-Induced Osteolytic Lesions through Upregulation of Extracellular Matrix Metalloproteinase Inducer/CD147 118
Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells 118
SMALL INTERFERING RNA (siRNA) FOR THE THERAPY OF TYPE 2 (ADO2) AUTOSOMAL DOMINANT OSTEOPETROSIS CAUSED BY CLCN7 (ADO2 CLCN7-DEPENDENT) GENE MUTATION 118
Lipocalin 2: A New Mechanoresponding Gene Regulating Bone Homeostasis 118
Lipocalin 2 serum levels correlate with age and bone turnover biomarkers in healthy subjects but not in postmenopausal osteoporotic women 118
beta-Arrestin2 Regulates RANKL and Ephrins Gene Expression in Response to Bone Remodeling in Mice 116
In vivo bone metastases, osteoclastogenic ability, and phenotypic characterization of human cancer cells 116
Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone 115
Apoptosis-associated speck-like protein containing a caspase-1 recruitment domain (ASC) contributes to osteoblast differentiation and osteogenesis 115
Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry 115
Extracellular Vesicles in Bone Tumors: How to Seed in the Surroundings Molecular Information for Malignant Transformation and Progression 115
C-SRC inhibition decreases breast cancer-induced lethality and incidence of experimental bone metastases in Balb nu/nu mice 114
The "soft" side of the bone: unveiling its endocrine functions. 114
Tyrosine kinase Src inhibitors: Cellular mechanisms for potential therapeutic applications in bone disease. 113
Reduction of c-Src activity by substituted 5,7-diphenyl-pyrrolo [2,3-d]-pyrimidines induces osteoclast apoptosis in vivo and in vitro. Involvement of ERK1/2 pathway 112
The C-terminal domain of chondroadherin: a new regulator of osteoclast motility counteracting bone loss 112
Individualized Whole-Body Vibration: Neuromuscular, Biochemical, Muscle Damage and Inflammatory Acute Responses 112
Evaluation of metastatic potential in prostate carcinoma: An in vivo model 111
Switching homes: how cancer moves to bone 111
Osteoblast-derived extracellular vesicles influence MNNG/HOS osteosarcoma cells, reducing their migration and affecting their metabolic activity and redox balance 111
c-Src-mediated regulation of Penk1 signal controls osteoblast differentiation 110
Small interfering RNA (siRNA) for the therapy of type 2 (ADO2) Autosomal Dominant Oosteopetrosis caused by CLCN7 (ADO2 CLCN7-dependent) gene mutation 109
Modeled microgravity stimulates osteoclastogenesis and bone resorption by increasing osteoblast RANKL/OPG ratio 109
Imbalance of osteoclastogenesis-regulating factors in celiac disease 109
A new heterozygous mutation (R714C) of the osteopetrosis gene, Pleckstrin Homolog Domain Containing Family M (With Run Domain) Member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclasts 109
A six-gene signature predicting breast cancer lung metastasis 108
Bone-Targeted Doxorubicin-Loaded Nanoparticles as a Tool for the Treatment of Skeletal Metastases 108
Bone metastasis pain, from the bench to the bedside 106
A model for in vitro three dimensional cultures of osteoblast-like cells 105
c-Src inhibition as a possible therapy against human breast cancer and bone metastases. 105
Cytokine imbalance in Celiac disease and parallel direct stimulation of osteoclastogenesis and osteoblast activity in vitro. 103
Role of estrogen receptor alpha in aggressiveness and osteoclastogenic potential of human breast carcinoma cells. 103
How the "seed" prepares the "soil": The bone/bone marrow pre-metastatic niche 103
Editorial: Extracellular vesicles as modulators of cancer cell adaptive responses linked to therapy resistance 102
Impaired skeletal development in interleukin-6 transgenic mice. A model for the impact of chronic inflammation on the growing skeletal system 102
Intratumoral acidosis fosters cancer-induced bone pain through the activation of the mesenchymal tumor-associated stroma in bone metastasis from breast carcinoma 102
Targeted Delivery of Lidocaine in Breast Cancer Cells via Zeolitic Imidazolate Framework‐8 Nanoparticles 100
HistoEnder: a 3D printer-based histological slide autostainer that retains 3D printer functions 100
Osteoclast receptors and signaling 100
Pre-proenkephalin 1 is Downregulated Under Unloading and is Involved in Osteoblast Biology 100
Suppression of EGF-R signaling reduces the incidence of prostate cancer metastasis in nude mice 99
Thyroid hormone effects on mouse oocyte maturation and granulosa cell aromatase activity 98
inhibition of protein kinase c-Src as a therapeutic approach for cancer and bone metastases 98
Circulating Extracellular Vesicles Express Receptor Activator of Nuclear Factor κB Ligand and Other Molecules Informative of the Bone Metabolic Status of Mouse Models of Experimentally Induced Osteoporosis 98
Osteopenia, decreased bone formation and impaired osteoblast development in Sox4 heterozygous mice 97
Alternative TrkA splicing and Cancer 97
A Combined Fc-OPG/hPTH(1-34) Therapy to Restore Impaired Skeletal Growth and Bone Loss in a Mouse Model of IL-6 Dependent Juvenile Inflammatory Diseases 97
Microgravity induces apoptosis and increases interleukin 6 expression in osteoblast-like cells. 97
Effectiveness Of Osteotropic Nanoparticles On Bone Metastases 97
Tumour-derived extracellular vesicles (EVs): A dangerous “message in a bottle” for bone 97
EFFECTS OF DUAL PI3K AND mTOR INHIBITION ON INCIDENCE AND LOCAL GROWTH OF PROSTATE CANCER BONE METASTASES 95
The matrix PROLINE/Arginine-Rich end leucin-rich repeat protein (PRELP) impairs osteoclastogenesis by inhibiting NF-kappaB activity 95
Regulatory loops involving IGFBP5 account for a fine tuning regulation of osteoblast and osteoclast activity in the context of the IL-6 pathway 95
Murine models of breast cancer bone metastasis. 95
Regulation by thyroid hormone of expression of basement membrane components in rat Sertoli cells 94
Bone and bone marrow: the same organ 94
Updates on osteoimmunology: What's new on the cross-talk between bone and immune system 94
Osteomimicry: how tumor cells try to deceive the bone 93
Totale 14.598
Salva come PNG Salva come JPEG
Categoria #
all - tutte 75.703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 75.703
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021420 0 0 0 0 0 0 0 0 0 45 291 84
2021/2022916 44 96 136 58 38 25 20 61 70 22 79 267
2022/20232.962 202 143 29 323 315 331 12 214 1.236 21 86 50
2023/2024928 228 55 42 119 69 212 7 43 4 25 16 108
2024/20253.022 54 48 291 145 397 290 386 275 590 159 224 163
2025/20268.330 344 1.030 2.509 904 514 499 1.083 225 519 703 0 0
Totale 20.795